SEALSQ 9M Revenue Up 65%, Reaffirms FY26 Guidance, But Q4 Run-Rate Needed Is Steep

What happened

SEALSQ Corp announced preliminary unaudited 9M 2026 revenue of $16.3 million, a 65% year-on-year increase, and reaffirmed its full-year 2026 revenue guidance of $27 million to $36 million. The 9M figure implies a Q4 requirement of $10.7 million to $19.7 million, which is nearly double to triple the $5.4 million average quarterly revenue in the first three quarters, indicating a backend-loaded year. The announcement does not break down revenue by product line, leaving unclear whether the growth is driven by legacy/IC’ALPS or the new post-quantum cryptography (PQC) products like QS7001 and QVault-TPM. This lack of detail perpetuates the key risk from the March 2026 master report that the PQC pipeline may not be converting into actual orders and that unaudited metrics have historically overstated financial strength. The stock remains below the $6.00 trim level from the master report, suggesting the market is not fully pricing in a successful Q4 ramp without further evidence.

Implication

The long-term investment case remains contingent on converting the stated >$200M pipeline into production orders for QS7001/QVault-TPM; the 9M revenue of $16.3M, if largely legacy-driven, would dilute the PQC narrative and compress the valuation multiple. The implied Q4 requirement of $10.7–19.7M suggests either a significant order inflow from PQC products or unusual seasonality, and absent filing-level disclosure, the risk-reward is unattractive at current levels above $4. The WAIT rating is justified: investors should look for audited results, product-mix transparency, and evidence of QVault-TPM shipments before adding positions, with attractive entry near $3.00 and trim above $6.00.

Thesis delta

The previous thesis hinged on audited FY2025 results and sustained quarterly revenue above $4M to confirm PQC shipment contribution. Now, 9M revenue of $16.3M exceeds the full-year FY2025 revenue of $18M within three quarters, but the lack of product-level detail means the growth could be entirely from legacy/IC’ALPS, not PQC. The reaffirmed FY2026 guidance of $27–36M implies a sharp Q4 acceleration that can only be validated by disclosed QVault-TPM shipments; until then, the PQC thesis remains unproven and the WAIT rating stands.